Page last updated: 2024-08-23

pirfenidone and Crohn Disease

pirfenidone has been researched along with Crohn Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dahlerup, JF; Dige, A; Kadir, SI; Kelsen, J; Kok Jensen, S; Wenzel Kragstrup, T	1

Other Studies

1 other study(ies) available for pirfenidone and Crohn Disease

Article	Year
Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn's disease. Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:11 Topics: Actins; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cells, Cultured; Collagen; Crohn Disease; Denmark; Endoscopy; Female; Fibroblasts; Fibrosis; Humans; Intestinal Mucosa; Linear Models; Male; Matrix Metalloproteinase 3; Pyridones; Tissue Inhibitor of Metalloproteinase-1	2016

Article

Year

Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn's disease.

Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:11

Topics: Actins; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cells, Cultured; Collagen; Crohn Disease; Denmark; Endoscopy; Female; Fibroblasts; Fibrosis; Humans; Intestinal Mucosa; Linear Models; Male; Matrix Metalloproteinase 3; Pyridones; Tissue Inhibitor of Metalloproteinase-1

2016